MARKET PULSE-Castlight, Raptor Pharma, Body Central, Ocean Power
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were little changed on Friday, keeping the S&P below a key support level for a second day, with investors reluctant to make big bets ahead of a referendum in Crimea this weekend. The Dow Jones industrial average was up 0.07 percent at 16,119.68, the S&P 500 was up 0.05 percent at 1,847.24 and the Nasdaq Composite was up 0.02 percent at 4,261.404.
** CASTLIGHT HEALTH INC, $37.81, +136.31 pct
Shares of the healthcare information provider more than doubled in value in their market debut, valuing the company at about $3.43 billion.
** RAPTOR PHARMACEUTICAL CORP, $11.77, -20.42 pct
Raptor Pharmaceutical forecast lower-than-expected 2014 sales of its only drug, which treats a genetic disorder that can cause irreversible tissue damage, organ failure and premature death.
"We've expressed concerns that the market for (the drug) Procysbi is not as large as some investors are estimating and ... guidance may be confirming that this might be the case," Wedbush analyst Christopher Marai told Reuters. He also said investors were concerned that the company would need to raise money to maintain its operations beyond the second half of 2015.
** BODY CENTRAL CORP, $2.19, -22.89 pct Continued...